JP2007056011A5 - - Google Patents

Download PDF

Info

Publication number
JP2007056011A5
JP2007056011A5 JP2006205560A JP2006205560A JP2007056011A5 JP 2007056011 A5 JP2007056011 A5 JP 2007056011A5 JP 2006205560 A JP2006205560 A JP 2006205560A JP 2006205560 A JP2006205560 A JP 2006205560A JP 2007056011 A5 JP2007056011 A5 JP 2007056011A5
Authority
JP
Japan
Prior art keywords
sarpogrelate hydrochloride
agent according
tablet
tablets agent
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006205560A
Other languages
Japanese (ja)
Other versions
JP4567640B2 (en
JP2007056011A (en
Filing date
Publication date
Application filed filed Critical
Priority to JP2006205560A priority Critical patent/JP4567640B2/en
Priority claimed from JP2006205560A external-priority patent/JP4567640B2/en
Publication of JP2007056011A publication Critical patent/JP2007056011A/en
Publication of JP2007056011A5 publication Critical patent/JP2007056011A5/ja
Application granted granted Critical
Publication of JP4567640B2 publication Critical patent/JP4567640B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (4)

塩酸サルポグレラート、及び製剤の崩壊を促す特徴を有する添加物としてカルボキシメチルセルロースを含有する錠剤であって、錠剤あたりの塩酸サルポグレラートの含量が４０〜９５重量％である錠剤。 A tablet containing carboxymethylcellulose as additive Addendum that have a feature to promote disintegration of sarpogrelate hydrochloride, and the formulation, the content of sarpogrelate hydrochloride per tablet tablets agent 40 to 95 wt%. 塩酸サルポグレラート、カルボキシメチルセルロース、及び結晶セルロースを含有する請求項１に記載の錠剤。 Tablets agent according to claim 1 containing sarpogrelate hydrochloride, carboxymethylcellulose, and microcrystalline cellulose. 水溶性コーティング及び／又は遮光コーティングが施された請求項１または２に記載の錠剤。 Tablets agent according to claim 1 or 2, a water-soluble coating and / or the light-shielding coating is applied. 錠剤中に含まれる塩酸サルポグレラートの８０重量％以上が１５分以内に溶出する溶出挙動を示す請求項１〜３のいずれかに記載の錠剤。
 Tablets agent according to any one of claims 1 to 3, or 8 0 wt% of sarpogrelate hydrochloride contained in the tablet agent exhibits a dissolution behavior eluting within 15 minutes.
JP2006205560A 2005-07-29 2006-07-28 Miniaturized sarpogrelate hydrochloride oral dosage form Active JP4567640B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006205560A JP4567640B2 (en) 2005-07-29 2006-07-28 Miniaturized sarpogrelate hydrochloride oral dosage form

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005219766 2005-07-29
JP2006205560A JP4567640B2 (en) 2005-07-29 2006-07-28 Miniaturized sarpogrelate hydrochloride oral dosage form

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010031733A Division JP4901966B2 (en) 2005-07-29 2010-02-16 Miniaturized sarpogrelate hydrochloride oral dosage form

Publications (3)

Publication Number Publication Date
JP2007056011A JP2007056011A (en) 2007-03-08
JP2007056011A5 true JP2007056011A5 (en) 2010-04-08
JP4567640B2 JP4567640B2 (en) 2010-10-20

Family

ID=37919796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006205560A Active JP4567640B2 (en) 2005-07-29 2006-07-28 Miniaturized sarpogrelate hydrochloride oral dosage form

Country Status (1)

Country Link
JP (1) JP4567640B2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5534645B2 (en) * 2008-01-11 2014-07-02 日医工株式会社 Oral dosage formulation containing sarpogrelate hydrochloride with excellent stability in an unwrapped state
JP2009209137A (en) * 2008-02-07 2009-09-17 Nipro Corp Tablet improved in palatability
JP2009269858A (en) * 2008-05-08 2009-11-19 Takada Seiyaku Kk Orally administrable preparation of sarpogrelate
TW201010743A (en) * 2008-09-05 2010-03-16 Otsuka Pharma Co Ltd Pharmaceutical solid preparation
JP5648480B2 (en) 2008-10-24 2015-01-07 東レ株式会社 Stable tablets containing 4,5-epoxymorphinan derivatives
ES2768349T3 (en) 2010-03-29 2020-06-22 Ea Pharma Co Ltd Pharmaceutical preparation comprising a phenylalanine derivative
WO2015046219A1 (en) * 2013-09-27 2015-04-02 株式会社ダイセル Intraorally disintegrable tablet comprising disintegrable granular composition
WO2017073738A1 (en) * 2015-10-29 2017-05-04 日本臓器製薬株式会社 Tablet having fexofenadine as effective component thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000034228A (en) * 1998-07-17 2000-02-02 Mitsubishi Chemicals Corp Agent for treatment of cervical vertebral sprain
JP4253371B2 (en) * 1998-07-17 2009-04-08 博道 萩原 Muscle clamp treatment
JP2000063270A (en) * 1998-08-20 2000-02-29 Mitsubishi Chemicals Corp Prophylactic and therapeutic agent for pancreatitis
JP2000219626A (en) * 1999-01-29 2000-08-08 Mitsubishi Chemicals Corp Therapeutic agent for keloid and/or hypertrophic scar
JP2000239163A (en) * 1999-02-19 2000-09-05 Mitsubishi Chemicals Corp Intestinal disease therapeutic agent

Similar Documents

Publication Publication Date Title
JP2007056011A5 (en)
NO20090554L (en) Pharmaceutical preparations of memantine
WO2008124617A3 (en) Rapidly dissolving pharmaceutical compositions comprising pullulan
ME00482B (en) Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent
WO2011084593A3 (en) Abuse-resistant formulations
CL2011001621A1 (en) Oral sustained release pharmaceutical composition comprising in a unit dosage form, a hydrophilic matrix, an opioid, a salt of an aine, and optionally an anionic surfactant; and use to prepare useful medicines in the prevention, relief or reduction of the level of pain and suppression of cough.
EP1897534A3 (en) Cosmetic or dermatologic compositions containing microspheres
WO2007002597A3 (en) Modified-release formulations of a bupropion salt
JP2011523372A5 (en)
WO2009117542A3 (en) Dimensionally stable, shaped articles comprised of dried, aggregated, water-swellable hydrogel microspheres and method of making same
WO2009019223A3 (en) Haemostatic wound care article
CL2013001136A1 (en) A phosphodiesterase 7 (pde7) inhibitory agent to be used in the treatment or reduction of the possibility of an addiction; and pharmaceutical composition, unit dosage form and pharmaceutical kit including phosphodiesterase 7 inhibitor (pde7) and an additional therapeutic agent.
ATE533476T1 (en) COMPRESSED PHARMACEUTICAL COMPOSITION WITH COATED PELLETS AND DIRECT COMPRESSION MIXTURE AND PROCESS FOR PRODUCTION THEREOF
JP2009502749A5 (en)
MY147641A (en) Fast release paracetamol tablets
WO2009022670A1 (en) Quickly disintegrating tablet
WO2010017215A3 (en) Biodegradable microspheres and methods of use thereof
JP2009538268A5 (en)
JP2010540619A5 (en)
JP2007063263A5 (en)
WO2008008592A3 (en) Multi-particulate formulation having tramadol in immediate and controlled release form
JP2014024874A5 (en)
SG169992A1 (en) Low flush niacin formulation
JP2007091706A5 (en)
TW201129385A (en) Film-coating agent for solid formulation and solid formulation using the same